[The use of platelet aggregation-inhibiting drugs in central vestibular pathology caused by atherosclerotic vascular diseases].
D001241:Aspirin / Q000627:therapeutic use*; D004176:Dipyridamole / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications*; D007759:Labyrinth Diseases / Q000188:drug therapy / Q000209:etiology; D010080:Oxazoles / Q000627:therapeutic use*; D010974:Platelet Aggregation / Q000187:drug effects*; D014722:Vestibule, Labyrinth
D010080:Oxazoles; D004176:Dipyridamole; D001241:Aspirin
Sull'uso di farmaci antiaggreganti piastrinici nella patologia vestibolare centrale da vasculopatia aterosclerotica.